Evaluation of drug-drug interactions of rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp substrates in patients with an advanced solid tumor

2019
journal article
article
cris.lastimport.scopus2024-04-07T17:48:37Z
dc.affiliationWydział Lekarski : Klinika Onkologiipl
dc.cm.date2020-01-07
dc.cm.id92052
dc.contributor.authorXiao, Jim J.pl
dc.contributor.authorNowak, Dorotapl
dc.contributor.authorRamlau, Rodrygpl
dc.contributor.authorTomaszewska-Kiecana, Monikapl
dc.contributor.authorWysocki, Piotr - 357742 pl
dc.contributor.authorIsaacson, Jeffpl
dc.contributor.authorBeltman, Jeripl
dc.contributor.authorNash, Eileenpl
dc.contributor.authorKaczanowski, Robertpl
dc.contributor.authorArold, Gerhardpl
dc.contributor.authorWatkins, Simonpl
dc.date.accessioned2020-01-17T10:02:46Z
dc.date.available2020-01-17T10:02:46Z
dc.date.issued2019pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.number1pl
dc.description.physical58-65pl
dc.description.points70pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume12pl
dc.identifier.doi10.1111/cts.12600pl
dc.identifier.eissn1752-8062pl
dc.identifier.issn1752-8054pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/144709
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa*
dc.rights.licenceCC-BY-NC-ND
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl*
dc.share.typeotwarte czasopismo
dc.subtypeArticlepl
dc.titleEvaluation of drug-drug interactions of rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp substrates in patients with an advanced solid tumorpl
dc.title.journalClinical and Translational Sciencepl
dc.typeJournalArticlepl
dspace.entity.typePublication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
0
Views per month